2022 Seattle Multidisciplinary Thoracic Oncology Conference

Seattle, WA US
October 22, 2022

This oncology conference titled,  “2022 Seattle Multidisciplinary Thoracic Oncology Conference," is an accredited continuing education activity that features lectures and discussions presented by leading experts in thoracic cancers who will provide a comprehensive overview of recent advances and controversies in the management of thoracic cancers.

The goal of this continuing education activity is to improve the knowledge, competence and performance of learners so that they can apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for their patients with thoracic cancers. 

Target Audience

  • Oncologists
  • Oncology fellows
  • Oncology nurses
  • Oncology nurse practitioners
  • Oncology physician assistants
  • Oncology pharmacists


Learning Objectives

  • Discuss the study design and primary endpoints of recently reported and ongoing trials that have influenced the changes in standards of care in thoracic cancers
  • Compare and contrast the safety and efficacy profiles of novel therapeutic strategies that impact management of patients with thoracic cancers
  • Integrate emerging evidence into treatment paradigms for treatment of thoracic cancers.
Course summary
Course opens: 
Course expires: 
Event starts: 
10/22/2022 - 8:00am PDT
Event ends: 
10/22/2022 - 5:00pm PDT
07:00 AM to 08:00 AM PST: Registration/Exhibition

08:00 AM to 08:05 AM PST: Welcome and opening remarks

08:05 AM to 09:50 AM PST:  Early stage non-small cell lung cancer

08:05 AM – 08:25 AM PST: Successes and challenges of lung cancer screening in 2022

08:25 AM – 08:45 AM PST: Management of early stage lung cancer – new surgical approaches

08:45 AM – 09:05 AM PST: Emerging data for radiation in early stage NSCLC

09:05 AM – 09:25 AM PST: Systemic therapy in resectable NSCLC

09:25 AM – 09:50 AM PST: Case-based discussion

09:50 AM to 10:20 AM PST: Break/Exhibits 

10:20 AM to 12:05 PM PST: Molecular testing/targeted therapy in lung cancer 

10:20 AM – 10:40 AM PST: Current standards and open questions in unresectable NSCLC

10:40 AM – 11:00 AM PST: Biomarker testing and current standards & barriers

11:00 AM – 11:20 PM PST: Expanding role of liquid biopsies – initial workup, serial assessment?

11:20 AM – 11:40 AM PST: New targets and targeted therapies

11:40 AM – 12:05 AM PST: Case-based discussion

12:05 PM – 13:00 PM PST: Lunch/Exhibits

13:00 PM – 14:15 PM PST: Immunotherapy in non-small cell lung cancer

13:00 PM – 13:20 PM PST: Evolving practices in immunotherapy for advanced NSCLC

13:20 PM – 13:40 PM PST: Vaccines and emerging immunotherapy approaches for NSCLC

13:40 PM – 14:00 PM PST: Oligometastatic disease and local consolidation therapy in NSCLC

14:00 PM – 14:15 PM PST: Case-based Discussion

14:15 PM – 16:00 PM PST: Small cell lung carcinoma/mesothelioma

14:15 PM – 14:35 PM PST: Developments and current questions in limited stage SCLC

14:35 PM – 14:55 PM PST: Developments in systemic management of extensive stage SCLC 

14:55 PM – 15:15 PM PST: Controversies in local therapy in extensive stage SCLC 

15:15 PM – 15:35 PM PST: Advances and path forward in management of mesothelioma

15:35 PM – 16:00 PM PST: Case-based discussion

16:00 PM PST: Adjourn
Grand Hyatt Seattle
721 Pine St.
Seattle, WA 98101
United States

Faculty information coming soon.


Accreditation information to come.

If you are interested in exhibiting at this meeting, please visit our exhibit page here - https://education.binayfoundation.org/exhibit-information


Please login or register to take this course.


Physicians (non-industry) - $200

Non-physician HPC (non-industry) - $125

Industry representatives - $650


If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:

  • If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
  • If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event. 

Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.


You may cancel your enrollment at any time. Cancellation fees apply as below:

  • 50% of the paid registration fee will be refunded if registration is cancelled six weeks before the conference.
  • No refunds will be issued if registration is cancelled after that date.  

No credits will be offered if you do not complete all required steps of this activity which include registration, participation in the live activity, and completion of pre & post tests as well as course evaluations.